US2024084340A1PendingUtilityA1
Heterologous production of 10-methylstearic acid
Est. expirySep 20, 2036(~10.2 yrs left)· nominal 20-yr term from priority
C12P 7/6409A23D 9/02C11B 1/10C11C 3/00C12N 9/001C12N 9/1007C12Q 1/686
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Nucleic acids and cells comprising a methyltransferase gene and/or a reductase gene are disclosed. These nucleic acids and cells may be used to produce branched (methyl)lipids, such as 10-methylstearate.
Claims
exact text as granted — not AI-modified1 . A yeast cell comprising a methyltransferase protein encoded by a methyltransferase gene and either a branched (methyl)lipid or an exomethylene-substituted lipid, wherein:
the methyltransferase protein comprises an amino acid sequence with at least 90% sequence identity with the amino acid sequence of SEQ ID NO:76; the branched (methyl)lipid or exomethylene-substituted lipid is a carboxylic acid, carboxylate, ester, thioester, or amide; and the branched (methyl)lipid comprises a saturated or unsaturated branched aliphatic chain comprising a branching methyl group or the exomethylene-substituted lipid comprises a branched aliphatic chain that is branched because the aliphatic chain is substituted with an exomethylene group.
2 . The yeast cell of claim 1 , wherein the branched (methyl)lipid or the exomethylene-substituted lipid comprises a linear lipid with a chain length of 14-20 carbons and a methyl branch at the Δ9, Δ10, or Δ11 position.
3 . The yeast cell of claim 2 , wherein the branched (methyl)lipid or the exomethylene-substituted lipid is a diacylglycerol, triacylglycerol, or phospholipid, and the diacylglycerol, triacylglycerol, or phospholipid comprises an ester of 10-methylstearate or an ester of 10-methylenestearate.
4 - 6 . (canceled)
7 . The yeast cell of claim 1 , wherein at least 1% by weight of the fatty acids of the yeast cell are one or more linear fatty acids with a chain length of 14-20 carbons and a methyl branch at the Δ9, Δ10, or Δ11 position.
8 . The yeast cell of claim 1 , wherein the yeast cell comprises at least 1% lipid as measured by % dry cell weight.
9 - 11 . (canceled)
12 . The yeast cell of claim 1 , further comprising a recombinant reductase gene.
13 . The yeast cell of claim 12 , wherein the recombinant reductase gene encodes tmsA from Thermomonospora curvata.
14 . The yeast cell of claim 1 , wherein:
the methyltransferase gene is codon-optimized for the yeast cell; or the yeast cell further comprises a reductase gene and the reductase gene is codon-optimized for the yeast cell.
15 - 19 . (canceled)
20 . The yeast cell of claim 1 , wherein the yeast cell is selected from the group consisting of Arxula, Saccharomyces , and Yarrowia.
21 . The yeast cell of claim 20 , wherein the yeast cell is selected from the group consisting of Arxula adeninivorans, Saccharomyces cerevisiae, and Yarrowia lipolytica.
22 - 23 . (canceled)
24 . The yeast cell of claim 1 , wherein the methyltransferase gene comprises either:
a nucleotide sequence with at least about 95% sequence identity with the nucleotide sequence of SEQ ID NO:75; or the nucleotide sequence of SEQ ID NO:75.
25 - 28 . (canceled)
29 . A method of producing a branched (methyl)lipid or exomethylene-substituted lipid, comprising contacting the yeast cell of claim 1 with oleic acid, methionine, or both oleic acid and methionine.
30 - 49 . (canceled)
50 . The yeast cell of claim 12 , wherein the reductase protein is in a fusion protein with the tmsB enzyme.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.